PT Darya-Varia Laboratoria Tbk (IDX:DVLA)

IDX:DVLA Revenue

PT Darya-Varia Laboratoria Tbk had revenue of 639.90B IDR in the quarter ending September 30, 2026, with 18.04% growth. This brings the company's total for the last twelve months to 2.45T, up 15.49% year-over-year. In the year 2025, PT Darya-Varia Laboratoria Tbk had annual revenue of 2.23T with 6.90% growth. That makes PT Darya-Varia Laboratoria Tbk the 20,423rd largest company in the world by revenue and 314th in Indonesia.

• Revenue (ttm): 2.45T
• Revenue Growth: +15.49%
• P/S Ratio: 0.72
• Revenue / Employee: 1.81B
• Employees: 1,357
• Market Cap: 1.76T

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Consumer Health Products 1.26T 56.4%
• Prescription Drugs 666.22B 29.9%
• Export & Toll Manufacturing 256.69B 11.5%
• Services 49.54B 2.2%

By Geography

Chart

• Indonesia 1.99T 90.0%
• Export 222.20B 10.0%

Fiscal year ended Dec 31, 2025 See the full IDX:DVLA breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.23T	144.15B	6.90%
Dec 31, 2024	2.09T	196.71B	10.40%
Dec 31, 2023	1.89T	-26.15B	-1.36%
Dec 31, 2022	1.92T	16.15B	0.85%
Dec 31, 2021	1.90T	71.19B	3.89%

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 1, 2026

Data Sources Report a data error